ALVEOLUS INC. TB-STS TRACHEOBRONCHIAL STENT SYSTEM— 510(k) K033990

Name: FDA 510(k) clearance K033990
Creator: U.S. Food and Drug Administration
Published: 2004-05-12

Substantially Equivalent

Alveolus, Inc.

FDA 510(k) clearance K033990 for ALVEOLUS INC. TB-STS TRACHEOBRONCHIAL STENT SYSTEM, Substantially Equivalent on 2004-05-12. Applicant: Alveolus, Inc.. Device class: 2.

Clearance details

Applicant: Alveolus, Inc.
Product code: Code JCT
Device class: Class 2
Regulation: 21 CFR 878.3720
Advisory panel: General, Plastic Surgery
Date received: 2003-12-23
Decision date: 2004-05-12
Decision: Substantially Equivalent
Clearance type: Special
Location: Charlotte, NC, US

Download summary PDF View on FDA.gov ↗

Recent devices under product code JCT

view all

K230269 — Ultraflex Tracheobronchial Stent System2023-07-14
K220424 — Through the Scope Tracheal Stent System2022-07-08
K212403 — Tracheal Stent System (Y-Shaped)2021-10-30
K202204 — Tracheal Stent System2021-09-01
K201342 — HANAROSTENT Trachea/Bronchium (CCC)2020-12-31

More clearances from Alveolus, Inc.

view all

K083625 — AERO DV TRACHEOBRONCHIAL STENT SYSTEM2009-03-11
K082284 — AERO TRACHEOBRONCHIAL STENT TECHNOLOGY SYSTEM2008-11-20
K080838 — ALVEOLUS ALIMAXX-E ESOPHAGEAL STENT SYSTEM2008-04-24
K072720 — ALIMAXX-B UNCOVERED BILIARY STENT SYSTEM2008-04-11
K071604 — ALVEOLUS AERO DV TRACHEOBRONCHIAL STENT SYSTEM2007-09-19

Adverse events under product code JCT

product code JCT

Death: 20
Injury: 211
Other: 1
Total: 232

Source: openFDA MAUDE database, 2020-01-01 through 2026-04-23. Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.